| MDL | - |
|---|---|
| Molecular Weight | 397.83 |
| Molecular Formula | C18H21ClFN3O4 |
| SMILES | [H]Cl.O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O |
Levofloxacin ((-)-Ofloxacin) hydrochloride is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrochloride inhibits the DNA gyrase and topoisomerase IV . Levofloxacin hydrochloride can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrochloride shows anti-orthopoxvirus activity [1] [2] [3] [4] [5] .
|
TOPO IV |
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT05728424 | Aga Khan University|Searle Pharmaceuticals |
Helicobacter Pylori Infection
|
September 20, 2022 | Phase 3 |
| NCT04107194 | University of Bari |
Helicobacter Pylori Infection|Antibiotic Resistant Infection|Antibiotic Resistant Strain
|
January 14, 2020 | Phase 3 |
| NCT03413020 | Shanghai Jiao Tong University School of Medicine |
Helicobacter Pylori Infection
|
January 3, 2018 | Phase 4 |
| NCT03087656 | University of Southern California |
Cholangitis
|
March 29, 2017 | Phase 4 |
| NCT00034736 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Pneumonia
|
August 2002 | Phase 3 |
| NCT00396084 | National Institute of Allergy and Infectious Diseases (NIAID) |
Tuberculosis
|
February 10, 2004 | Phase 1|Phase 2 |
| NCT04212403 | Jessa Hospital |
Urosepsis|Bladder Cancer|Prostate Hyperplasia|Antibiotic Resistant Strain|Antibiotic Resistant Infection|Antibiotic-associated Diarrhea|Antibiotic Toxicity
|
September 17, 2018 | Not Applicable |
| NCT00136344 | City, University of London|The European Society of Cataract and Refractive Surgeons(ESCRS)|Santen Gmbh |
Endophthalmitis
|
September 2003 | Not Applicable |
| NCT02024555 | Vanderbilt University|National Heart, Lung, and Blood Institute (NHLBI)|Vanderbilt University Medical Center |
Sarcoidosis; Antimycobacterial Therapy
|
March 2014 | Phase 2 |
| NCT05129176 | Shandong University |
Helicobacter Pylori Infection
|
November 23, 2021 | Phase 4 |
| NCT04039412 | Ayman Magd Eldin Mohammad Sadek|Zagazig University |
Helicobacter Pylori Infection
|
June 1, 2018 | Phase 4 |
| NCT00906048 | Sanofi |
Infection
|
April 2009 | Phase 3 |
| NCT01096849 | Achaogen, Inc. |
Complicated Urinary Tract Infection|Acute Pyelonephritis
|
July 13, 2010 | Phase 2 |
| NCT02128308 | Seoul National University Hospital |
Healthy
|
November 2013 | Phase 1 |
| NCT01529476 | TaiGen Biotechnology Co., Ltd.|Qualitix Clinical Research Co., Ltd.|Parexel|PPD |
Pneumonia
|
April 2011 | Phase 3 |
| NCT02166476 | Melinta Therapeutics, Inc.|Department of Health and Human Services |
Urinary Tract Infection Complicated|Acute Pyelonephritis
|
November 20, 2014 | Phase 3 |
| NCT02884713 | King Faisal Specialist Hospital & Research Center |
GASTRITIS
|
June 2013 | Not Applicable |
| NCT05079620 | UConn Health |
Aspiration|Aspiration Pneumonia
|
November 30, 2021 | Phase 4 |
| NCT00176306 | Joel Thompson, PhD|Ortho-McNeil Pharmaceutical|University of Kentucky |
Obesity|Critical Illness
|
January 2005 | Phase 4 |
| NCT05741632 | Indonesia University|Ferron Par Pharmaceuticals |
Cataract
|
February 1, 2023 | Phase 1 |
| NCT00593567 | Innocoll|Premier Research Group plc |
Diabetic Foot Ulcer
|
December 2007 | Phase 2 |
| NCT03697993 | National Institute of Allergy and Infectious Diseases (NIAID) |
Urinary Tract Infection
|
November 7, 2018 | Phase 4 |
| NCT04062201 | Wits Health Consortium (Pty) Ltd|Regents of the University of California|University of Cape Town|Perinatal HIV Research Unit of the University of the Witswatersrand |
Tuberculosis|Pre-XDR-TB|Extensively Drug-Resistant Tuberculosis|Multi Drug Resistant Tuberculosis|Rifampicin Resistant Tuberculosis
|
August 22, 2019 | Phase 3 |
| NCT03159845 | Azienda Ospedaliero, Universitaria Pisana |
Stem Cell Transplant Complications
|
January 1, 2014 | Phase 2 |
| NCT04090021 | Konstantopoulio-Patission General Hospital of Nea Ionia |
Helicobacter Pylori Infection
|
September 1, 2019 | Phase 4 |
| NCT05398679 | Fundacion Clinic per a la Recerca Biomédica |
Endocarditis Infective
|
June 1, 2022 | Phase 4 |
| NCT00000796 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections|Tuberculosis
|
Not Applicable | |
| NCT01761201 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|Spanish Network for Research in Infectious Diseases |
Latent Tuberculosis Infection|Infection in Solid Organ Transplant Recipients
|
January 2012 | Phase 3 |
| NCT00257036 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Skin Diseases, Infectious|Cellulitis
|
July 1991 | Phase 2|Phase 3 |
| NCT01988779 | University of Rochester |
Chronic Rhinosinusitis
|
October 2013 | Phase 3 |
| NCT05863858 | Iyad Naeem Muhammad, PhD|University of Karachi |
Helicobacter Pylori Infection|Helicobacter Pylori Infection, Susceptibility to
|
June 1, 2020 | Phase 3 |
| NCT03032510 | Tetraphase Pharmaceuticals, Inc.|La Jolla Pharmaceutical Company |
Complicated Urinary Tract Infections
|
January 2017 | Phase 3 |
| NCT00516958 | Oculus Innovative Sciences, Inc. |
Foot Ulcer, Diabetic
|
May 2007 | Phase 2 |
| NCT01618591 | Uniformed Services University of the Health Sciences|Navy Bureau of Medicine and Surgery|Ministry of Defence, United Kingdom|Naval Medical Research Center|Naval Medical Research Unit- 3|United States Army Medical Unit - Kenya|United States Naval Medical Center, Portsmouth|Naval Medical Research Unit- 6 |
Acute Watery Diarrhea|Dysentery+Febrile Diarrhea
|
September 2012 | Not Applicable |
| NCT01371656 | Children´s Oncology Group|National Cancer Institute (NCI) |
Acute Leukemias of Ambiguous Lineage|Bacterial Infection|Diarrhea|Fungal Infection|Musculoskeletal Complications|Neutropenia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
|
September 2011 | Phase 3 |
| NCT02789865 | First Affiliated Hospital Xi´an Jiaotong University|3201 Hospital in Hanzhong|Second Affiliated Hospital of Xi´an Jiaotong University |
Acute Appendicitis
|
May 2016 | Phase 2 |
| NCT00630019 | Santen Inc.|Vistakon Pharmaceuticals |
Cataract
|
February 2008 | Phase 4 |
| NCT01742429 | Shanghai Jiao Tong University School of Medicine |
Cure Rate of Helicobacter Pylori Infection
|
November 2012 | Phase 4 |
| NCT00665327 | Bayer |
Pneumonia
|
November 2002 | Phase 4 |
| NCT03139253 | Yanqing Li|Shandong University |
Antimicrobial Susceptibility Testing|Triple Therapy
|
May 30, 2017 | Phase 4 |
| NCT05339295 | University of Karachi|Merck Pvt. Ltd, Pakistan|Center for bioequivalence studies and clinical reseach (CBSCR), ICCBS, University of Karachi |
Healthy|Pharmacokintetics
|
July 11, 2012 | Phase 1 |
| NCT02901288 | Beijing Chest Hospital|Hubei Provincial Center for Disease Control and Prevention|Centre for Tuberculosis Control of Guangdong Province|Hunan Institute For Tuberculosis Control|Anhui Chest Hospital|Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control|Wuhan Institute for Tuberculosis Control|Shanghai Pulmonary Hospital, Shanghai, China|Shenyang Chest Hospital|Changchun Infectious Disease Hospital|First Affiliated Hospital of Xinjiang Medical University|Public Health Clinical Center of Chengdu|Taiyuan Fourth People´s Hospital|The Sixth People´s Hospital of Nantong|The Tuberculosis Prevention and Treatment Hospital of Shanxi Province|Beijing Research Institute for Tuberculosis Control|Infectious Disease Prevention Hospital in Heilongjiang Province|The Third People´s Hospital of Zhenjiang|Tianjin centers for Disease Control and Prevention|Harbin Chest Hospital|Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC|Heilongjiang Province center for tuberculosis Control and Prevention|Tianjin Haihe Hospital|The Infectious Disease Hospital of Wangkai Zaozhuang|The Third People´s Hospital of Kunming City|Kaifeng Central Hospital|The Infectious Hospital of Hebi|Pulmonary Hospital of Lanzhou|The Fourth People´s Hospital of Ningxia Autonomous Region|The 4th People´s Hospital of Qinghai Province|The Fifth People´s Hospital of Suzhou|Chongqing Infectious Disease Medical Center|Tuberculosis Hospital in Jilin Province|Sixth People´s Hospital of Nanyang City|Wuhan Union Hospital, China |
Tuberculosis, Pulmonary
|
August 2016 | Phase 4 |
| NCT04456712 | Beni-Suef University |
QTc Prolongation, Hyperglycemia, Hypoglycemia
|
June 1, 2018 | Phase 4 |
| NCT00402688 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Prostatitis
|
November 2006 | Phase 3 |
| NCT00565123 | Laser Microsurgery Centre, Poland|Katedra I Klinika Okulistyki II Wydz. Lek. AM w Warszawie,|University Hospital No 1 Wroclaw|MedSource Polska |
Bacterial Conjunctivitis
|
September 2004 | Phase 2|Phase 3 |
| NCT02573610 | Santen Pharmaceutical Co., Ltd. |
Cataract Surgery
|
September 21, 2015 | Phase 3 |
| NCT00789997 | Ottawa Hospital Research Institute |
COPD Exacerbation
|
November 2008 | Phase 2|Phase 3 |
| NCT02712502 | Dr. Reddy´s Laboratories Limited |
Rhinosinusitis
|
September 2014 | |
| NCT03148366 | National Taiwan University Hospital |
Helicobacter
|
February 2015 | Phase 3 |
| NCT03828201 | Boston University|Novartis Pharmaceuticals|Pfizer|Otsuka Pharmaceutical Co., Ltd.|University of California, San Francisco|Westat|National Institute of Allergy and Infectious Diseases (NIAID)|University of Colorado, Denver|Harvard Medical School (HMS and HSDM)|National Lung Hospital, Vietnam|De La Salle Health Sciences Institute, Philippines |
Tuberculosis, Multidrug-Resistant
|
June 7, 2022 | Phase 2 |
| NCT02454205 | University of Cape Town|University of Limpopo|Walter Sisulu University|University of Stellenbosch|University of Cape Town Lung Institute |
Tuberculosis|Multidrug Resistant Tuberculosis|Extensively-drug Resistant Tuberculosis
|
November 12, 2015 | Phase 2|Phase 3 |
| NCT01081964 | IASO Pharma Inc. |
Community Acquired Pneumonia
|
March 2010 | Phase 2 |
| NCT02094703 | Dr Cipto Mangunkusumo General Hospital|Astellas Pharma Indonesia Inc.|Pharos Life Corporation |
Urinary Tract Infection
|
April 2013 | Phase 4 |
| NCT02619994 | Seoul National University Hospital|Asan Medical Center|Dankook University|International Tuberculosis Research Center|Pusan National University Yangsan Hospital|Pusan National University Hospital|Samsung Medical Center|Severance Hospital|SMG-SNU Boramae Medical Center|Incheon St.Mary´s Hospital|Ulsan University Hospital|Korean Institute of Tuberculosis|National Medical Center, Seoul|Korean Center for Disease Control and Prevention|Korea University |
Tuberculosis, Multidrug-Resistant
|
January 2016 | Phase 2 |
| NCT02212795 | Dong Wha Pharmaceutical Co. Ltd. |
Healthy
|
May 2014 | Phase 1 |
| NCT02618057 | Seoul National University Hospital |
Mycoplasma Pneumoniae Pneumonia
|
June 2016 | Phase 4 |
| NCT04810793 | Shandong University|Taian City Central Hospital|Dezhou People´s Hospital|Weifang Medical University|The Affiliated Hospital of Qingdao University|Shengli Oilfield Hospital |
Helicobacter Pylori
|
July 1, 2020 | |
| NCT02800785 | University of Washington|Patient-Centered Outcomes Research Institute |
Appendicitis
|
May 2016 | Not Applicable |
| NCT00840580 | Alcon Research |
Cataract Extraction
|
January 2009 | Phase 4 |
| NCT02693574 | Damascus Hospital|UNIPHARMA. Universal Pharmaceutical Industries|Ibn Alhaytham Pharma. Industries Co |
Helicobacter Pylori Gastrointestinal Tract Infection
|
December 1, 2015 | Phase 4 |
| NCT03098485 | Washington University School of Medicine |
Microbiota|Anti-bacterial Agents
|
January 2017 | Not Applicable |
| NCT05867654 | University of Louisville|Osteo Science Foundation |
Osteomyelitis of Jaw
|
May 1, 2023 | |
| NCT01710488 | Fadoi Foundation, Italy |
COPD Exacerbation
|
May 2009 | Phase 4 |
| NCT05313750 | Shanghai Pulmonary Hospital, Shanghai, China |
Acute Exacerbation of Bronchiectasis
|
June 30, 2021 | Phase 4 |
| NCT00081575 | Wyeth is now a wholly owned subsidiary of Pfizer |
Community-Acquired Infections|Bacterial Pneumonia|Cross Infection
|
January 2004 | Phase 3 |
| NCT04639817 | National Institutes of Health Clinical Center (CC)|Duke University|Emory University |
Stenotrophomonas Infection
|
August 14, 2020 | |
| NCT02486627 | Achaogen, Inc. |
Complicated Urinary Tract Infection|Acute Pyelonephritis
|
January 11, 2016 | Phase 3 |
| NCT03511118 | Duke University|The Emmes Company, LLC|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
Lactating Women on Select DOI|Breastfed Infants of Mothers on Select DOI
|
October 4, 2018 | |
| NCT05850117 | Kaohsiung Medical University |
Helicobacter Pylori Eradication
|
February 10, 2020 | Not Applicable |
| NCT02439632 | Lee´s Pharmaceutical Limited |
Acute Lower Urinary Tract Infection
|
February 2014 | Phase 3 |
| NCT05250050 | Shanghai Zhongshan Hospital |
Helicobacter Pylori Infection
|
March 25, 2022 | Phase 4 |
| NCT00362869 | National Institute of Allergy and Infectious Diseases (NIAID) |
Escherichia Coli Infections
|
February 2008 | Phase 1 |
| NCT05023577 | Shanghai Zhongshan Hospital |
Helicobacter Pylori Infection
|
August 26, 2021 | Phase 4 |
| NCT05575427 | Mahidol University |
Hospital Infections
|
November 24, 2022 | Phase 4 |
| NCT01034176 | Brigham and Women´s Hospital |
BK Viremia
|
February 2009 | Phase 4 |
| NCT03673956 | Mayo Clinic |
Chronic Rhinosinusitis (Diagnosis)
|
September 26, 2018 | Phase 1|Phase 2 |
| NCT00764582 | Santen Inc.|Vistakon Pharmaceuticals |
Corneal Transplantation
|
September 2008 | Phase 4 |
| NCT00453349 | Bayer |
Pelvic Inflammatory Disease
|
January 2007 | Phase 3 |
| NCT00659646 | Innocoll|Premier Research Group plc |
Diabetic Foot Ulcer
|
April 2008 | Phase 2 |
| NCT00602589 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Healthy
|
October 2002 | Phase 1 |
| NCT00164112 | Bassett Healthcare|PriCara, Unit of Ortho-McNeil, Inc. |
Healthy
|
November 2004 | Phase 4 |
| NCT00236821 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Pneumonia
|
March 2001 | Phase 3 |
| NCT04403334 | Peregrine Eye and Laser Institute |
Cataract Senile|Endophthalmitis|Antibiotic Side Effect|Safety Issues
|
January 2, 2018 | Phase 4 |
| NCT02028754 | Allergan |
Dry Eye Syndromes|Cataract
|
July 2011 | Phase 4 |
| NCT02789579 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
Complication of Surgical Procedure
|
September 2016 | Early Phase 1 |
| NCT05741905 | Yi Yang|The First Hospital of Jilin University |
Acute Ischemic Stroke
|
June 1, 2023 | Not Applicable |
| NCT00752947 | Beijing Hospital |
Community-Acquired Pneumonia
|
September 2008 | Phase 4 |
| NCT03178292 | Mansoura University |
Percutaneous Nephrolithotomy|Infection|Sepsis|Antibiotics
|
June 15, 2017 | Not Applicable |
| NCT04502095 | Roswell Park Cancer Institute |
Bladder Carcinoma|Refractory Bladder Carcinoma|Urinary Tract Infection
|
September 2, 2020 | Phase 4 |
| NCT00429975 | Hospital Mutua de Terrassa|Fondo de Investigacion Sanitaria |
Pneumonia, Pneumococcal
|
August 2004 | Phase 4 |
| NCT03698682 | University of Monastir |
Chronic Obstructive Pulmonary Disease
|
January 1, 2018 | Phase 2 |
| NCT03257423 | Turku University Hospital|Tampere University Hospital|Oulu University Hospital|Kuopio University Hospital|Helsinki University Central Hospital|Jyväskylä Central Hospital |
Acute Appendicitis
|
April 4, 2017 | Not Applicable |
| NCT00035347 | Pfizer |
Community-Acquired Pneumonia (CAP)
|
January 2001 | Phase 4 |
| NCT02735707 | UMC Utrecht|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|National Intensive Care Surveillance MORU |
Community-acquired Pneumonia, Influenza, COVID-19
|
April 11, 2016 | Phase 3 |
| NCT00044473 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Otitis Media
|
November 2002 | Phase 3 |
| NCT00210886 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Urinary Tract Infections|Pyelonephritis
|
October 2004 | Phase 3 |
| NCT00257062 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Skin Diseases, Infectious
|
January 1993 | Phase 3 |
| NCT03555526 | National Taiwan University Hospital |
H Pylori Infection
|
December 15, 2017 | Phase 4 |
| NCT00258089 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Urinary Tract Infections|Bacteriuria|Urologic Diseases|Pyelonephritis|Neurogenic Bladder
|
June 1993 | Phase 3 |
| NCT02975570 | Boston University|Westat|University of Florida |
Tuberculosis Multi Drug Resistant Active
|
August 2017 | Phase 3 |
| NCT00236808 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Prostatitis
|
May 2000 | Phase 3 |
| NCT00645437 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Renal Diseases
|
October 2004 | Phase 1 |
| NCT01353339 | Ottawa Hospital Research Institute|Canadian Institutes of Health Research (CIHR)|St. Paul´s Hospital, Canada|Vancouver General Hospital|University of Alberta|University of Manitoba|University Health Network, Toronto|Unity Health Toronto|St. Joseph´s Healthcare Hamilton|London Health Sciences Centre|McGill University Health Centre+Research Institute of the McGill University Health Centre|Dalhousie University |
Disease Due to BK Polyomavirus|Kidney Transplant Infection
|
November 2011 | Phase 4 |
| NCT00250718 | New Mexico Cancer Care Alliance |
Non-Hodgkin´s Lymphoma|Cancer
|
October 2004 | Phase 2 |
| NCT00548002 | University of Helsinki |
Staphylococcus Aureus|Bacteremia|Endocarditis|Sepsis
|
January 1999 | |
| NCT01524302 | Gary E. Stein, Pharm.D.|Forest Laboratories|Michigan State University |
Pneumonia, Bacterial|Community-acquired
|
February 2012 | Phase 4 |
| NCT02422706 | Sherief Abd-Elsalam|Tanta University |
Helicobacter-associated Gastritis
|
January 2015 | Phase 3 |
| NCT00392275 | Indiana University School of Medicine|Indiana University |
Cataract
|
November 2002 | Phase 4 |
| NCT02148016 | Sun Yat-sen University |
Corneal Disease|Pterygium|Myopia|Hyperopia
|
December 2012 | Phase 1|Phase 2 |
| NCT04374188 | Diaa Eldin Taha Ramadan Mohamed|Kafrelsheikh University |
Nephrolithiasis
|
September 1, 2019 | Not Applicable |
| NCT01168713 | Melinta Therapeutics, Inc. |
Community-Acquired Bacterial Pneumonia
|
August 2010 | Phase 2 |
| NCT00236522 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Sinusitis
|
October 2002 | Phase 3 |
| NCT02711943 | Dr. Reddy´s Laboratories Limited |
Chronic Prostatitis
|
July 2013 | |
| NCT00245791 | University of Manitoba |
Complicated Urinary Infection
|
October 2004 | Phase 4 |
| NCT01467297 | University of Milan |
COPD Exacerbation
|
January 2012 | Phase 4 |
| NCT00643734 | Pfizer |
Pneumonia
|
April 2003 | Phase 3 |
| NCT04432233 | Shanghai Jiao Tong University School of Medicine |
Helicobacter Pylori Infection|Intravenous Drug Usage
|
June 15, 2020 | Phase 4 |
| NCT00001033 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections|Tuberculosis
|
Phase 3 | |
| NCT04359966 | Slovenian Society for Gastroenterology and Hepatology|KRKA |
Helicobacter Pylori Infection|Eradication Treatments
|
May 10, 2020 | Not Applicable |
| NCT02754765 | Médecins Sans Frontières, France|Partners in Health|Harvard Medical School (HMS and HSDM)|Epicentre|Institute of Tropical Medicine, Belgium|Socios En Salud, Peru|Interactive Research and Development |
Tuberculosis, Multidrug-Resistant|Infection, Bacterial|Pulmonary Tuberculoses
|
December 2016 | Phase 3 |
| NCT05306223 | Beijing Chest Hospital |
Tuberculosis, Multidrug-Resistant
|
May 10, 2022 | Phase 4 |
| NCT04682288 | PolyActiva Pty Ltd |
Cataract
|
January 4, 2021 | Phase 1 |
| NCT03708848 | Shanghai Jiao Tong University School of Medicine |
Helicobacter Pylori Infection
|
December 5, 2018 | Phase 4 |
| NCT02621359 | Tanta University |
Dyspepsia
|
January 2015 | Phase 3 |
| NCT00020865 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) |
Fever, Sweats, and Hot Flashes|Infection|Leukemia|Lymphoma|Neutropenia|Unspecified Adult Solid Tumor, Protocol Specific
|
September 2001 | Phase 3 |
| NCT02757365 | West China Hospital |
Prostate Cancer
|
April 2014 | Phase 4 |
| NCT02067780 | University of Monastir |
Chronic Obstructive Pulmonary Disease
|
May 1, 2017 | Phase 3 |
| NCT00215007 | Charite University, Berlin, Germany |
Malignancy|Allogeneic Stem Cell Transplantation
|
Phase 2|Phase 3 | |
| NCT05799326 | Yi Yang|The First Hospital of Jilin University |
Acute Ischemic Stroke
|
June 30, 2023 | Not Applicable |
| NCT05743101 | Yi Yang|The First Hospital of Jilin University |
Acute Ischemic Stroke
|
February 13, 2023 | Not Applicable |
| NCT00269932 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Bronchitis, Chronic
|
August 1993 | Phase 3 |
| NCT00277511 | Sanofi |
Prostatitis
|
March 2003 | Phase 3 |
| NCT03201796 | Aziende Chimiche Riunite Angelini Francesco S.p.A|Hippocrates Research |
Chronic Bacterial Prostatitis
|
February 2, 2016 | Phase 2 |
| NCT00249210 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Sinusitis|Maxillary Sinusitis
|
August 1993 | Phase 3 |
| NCT02600806 | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
Community-acquired Pneumonia
|
May 2005 | Phase 4 |
| NCT02409290 | IUATLD, Inc|Medical Research Council|Institute of Tropical Medicine, Belgium|Liverpool School of Tropical Medicine|Rede TB |
MDR-TB
|
April 2016 | Phase 3 |
| NCT00005590 | Cancer Research Campaign Clinical Trials Centre|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Breast Cancer|Extragonadal Germ Cell Tumor|Infection|Lung Cancer|Lymphoma|Ovarian Cancer|Small Intestine Cancer|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific
|
August 1999 | Phase 3 |
| NCT00169585 | GlaxoSmithKline |
Prostatic Hyperplasia|Prostatitis
|
March 2005 | Phase 3 |
| NCT00644449 | Pfizer |
Bronchitis, Chronic
|
January 2003 | Phase 3 |
| NCT00253955 | Sanofi |
Pneumonia
|
June 2003 | Phase 3 |
| NCT01875263 | Fundación Pública Andaluza Progreso y Salud|Andalusian Network for Design and Translation of Advanced Therapies |
Staphylococcus
|
May 2013 | Phase 3 |
| NCT01978938 | Tetraphase Pharmaceuticals, Inc.|La Jolla Pharmaceutical Company |
cUTI
|
October 6, 2014 | Phase 3 |
| NCT00258102 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Urinary Tract Infections|Bacterial Infections|Bacteriuria|Urologic Diseases
|
January 1993 | Phase 3 |
| NCT02157571 | Lee´s Pharmaceutical Limited |
Acute Exacerbations of Chronic Bronchitis
|
June 2013 | Phase 3 |
| NCT00000778 | National Institute of Allergy and Infectious Diseases (NIAID) |
HIV Infections|Tuberculosis
|
Phase 1 | |
| NCT05441930 | PolyActiva Pty Ltd |
Cataract
|
June 23, 2023 | Phase 1 |
| NCT00236652 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Maxillary Sinusitis
|
November 2003 | Phase 3 |
| NCT05219877 | Indonesia University |
Urinary Tract Infections
|
April 4, 2019 | Phase 2 |
| NCT00002249 | R W Johnson Pharmaceutical Research Institute|NIH AIDS Clinical Trials Information Service |
HIV Infections
|
Phase 1 | |
| NCT00376376 | Michigan State University|PriCara, Unit of Ortho-McNeil, Inc. |
Healthy Volunteers
|
September 2006 | Not Applicable |
| NCT00249197 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Skin Diseases, Bacterial
|
January 1997 | Phase 3 |
| NCT02018081 | University Hospital, Toulouse |
Intensive Care Unit Syndrome|Community-acquired Pneumonia
|
March 2012 | Phase 4 |
| NCT02699658 | Prince of Songkla University |
Healthy Volunteers
|
October 2013 | Phase 2 |
| NCT01345929 | Cubist Pharmaceuticals LLC |
Complicated Urinary Tract Infection|Pyelonephritis
|
June 20, 2011 | Phase 3 |
| NCT03474198 | University College, London|National University Hospital, Singapore|Singapore Clinical Research Institute (SCRI) |
Tuberculosis, Pulmonary
|
March 21, 2018 | Phase 2|Phase 3 |
| NCT00491049 | Ludwig-Maximilians - University of Munich|Santen Gmbh |
Conjunctival Bacterial Flora
|
September 2004 | Phase 4 |
| NCT02935010 | Shanghai Jiao Tong University School of Medicine |
Helicobacter Pylori Infection
|
February 5, 2017 | Phase 4 |
| NCT00257140 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Bronchitis|Bronchitis, Chronic
|
June 1931 | Phase 2|Phase 3 |
| NCT01109823 | University Ghent |
Infection
|
May 19, 2010 | Phase 3 |
| NCT00601432 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Healthy
|
October 2002 | Phase 1 |
| NCT02205112 | TaiGen Biotechnology Co., Ltd. |
Community-acquired Pneumonia
|
June 2014 | Phase 3 |
| NCT03472144 | LifeBridge Health |
Chronic Sinusitis, Ethmoidal|Chronic Sinusitis - Ethmoidal Anterior|Chronic Sinusitis|Chronic Sinusitis - Ethmoidal, Posterior|Chronic Sinusitis, Sphenoidal|Chronic Sinusitis - Frontoethmoidal|Nasal Polyps|Nasal Polyp - Posterior
|
July 7, 2017 | Phase 3 |
| NCT04352062 | Medical University of Lodz |
Melatonin Deficiency
|
January 9, 2011 | Not Applicable |
| NCT02988089 | Shandong University|Shandong Provincial Hospital|General Hospital of Jinan Military Region|Binzhou People´s Hospital|Liaocheng People´s Hospital |
Helicobacter Pylori Infection|Antimicrobial Susceptibility Testing
|
April 20, 2017 | Phase 4 |
| NCT04204382 | Shanxi Zhendong Pharmacy Co., Ltd |
Radiation-induced Oral Mucositis
|
December 12, 2019 | Phase 4 |
| NCT01918397 | Boston University|National Institute of Allergy and Infectious Diseases (NIAID)|Centers for Disease Control and Prevention|Macleods Pharmaceuticals, Ltd |
Tuberculosis, Multidrug-Resistant
|
January 2015 | Phase 2 |
| NCT03739528 | NTC srl |
Cataract
|
September 3, 2018 | Phase 3 |
| NCT00239161 | University of Manitoba|Ortho-McNeil Pharmaceutical|Janssen-Ortho Inc., Canada|PriCara, Unit of Ortho-McNeil, Inc. |
Acute Uncomplicated Pyelonephritis
|
September 2004 | Phase 4 |
| NCT00643409 | Pfizer |
Maxillary Sinusitis
|
January 2003 | Phase 3 |
| NCT03757234 | Paratek Pharmaceuticals Inc |
Acute Pyelonephritis
|
November 19, 2018 | Phase 2 |
| NCT04626193 | Damascus Hospital |
Helicobacter Pylori Infection
|
October 31, 2020 | Phase 4 |
| NCT04212429 | National University of Malaysia|Santen Pharmaceutical Co., Ltd. |
Endophthalmitis Postoperative
|
September 23, 2019 | Phase 1|Phase 2 |
| NCT00495339 | Sanofi |
Tuberculosis, Pulmonary
|
June 2007 | Phase 4 |
| NCT04951986 | University of Cape Town |
Disseminated Tuberculosis|HIV
|
August 11, 2021 | Phase 3 |
| NCT05061732 | Shanghai Zhongshan Hospital |
Helicobacter Pylori Infection
|
September 30, 2021 | Phase 4 |
| NCT01537250 | TaiGen Biotechnology Co., Ltd. |
Community-acquired Pneumonia
|
August 2009 | Phase 2 |
| NCT04348786 | Damascus Hospital |
Helicobacter Pylori Infection
|
February 1, 2019 | Phase 4 |
| NCT02466919 | Chung-Tai Wu|Ministry of Health and Welfare, Taiwan|National Cheng-Kung University Hospital |
Helicobacter Pylori Infection
|
May 2014 | Phase 4 |
| NCT03832465 | Mackay Memorial Hospital |
Helicobacter Pylori Infection
|
June 14, 2019 | Phase 4 |
| NCT03160807 | Dr. Reddy´s Laboratories Limited |
Urinary Tract Infection
|
April 15, 2017 | Phase 4 |
| NCT04214821 | National University of Malaysia|Santen Pharmaceutical Co., Ltd. |
Endophthalmitis
|
September 23, 2019 | Phase 1|Phase 2 |
| NCT03658291 | China Academy of Chinese Medical Sciences|Xiyuan Hospital of China Academy of Chinese Medical Sciences|Shanghai University of Traditional Chinese Medicine|Guangdong Provincial Hospital of Traditional Chinese Medicine|Hubei Hospital of Traditional Chinese Medicine|Chengdu University of Traditional Chinese Medicine|Yunnan Provinical Hospital of Traditional Chinese Medicine |
Urinary Tract Infection Lower Acute
|
January 1, 2019 | Phase 4 |
| NCT00257049 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PriCara, Unit of Ortho-McNeil, Inc. |
Pneumonia
|
January 1984 | Phase 2|Phase 3 |
| NCT04212078 | National University of Malaysia|Santen Pharmaceutical Co., Ltd. |
Endophthalmitis Postoperative
|
July 29, 2019 | Phase 1|Phase 2 |
| NCT03021590 | Damascus Hospital |
Helicobacter Pylori Gastrointestinal Tract Infection
|
June 1, 2017 | Phase 4 |
| NCT05302531 | Central Hospital, Nancy, France|Société Francophone Nutrition Clinique et Métabolisme|FIlière des Maladies rares Abdomino-THOraciques|Fresenius Kabi |
Short Bowel Syndrome|Infection, Bacterial
|
December 9, 2022 | Phase 1 |
| NCT02701608 | University Hospital, Tours |
Infective Endocarditis
|
February 29, 2016 | Phase 3 |
| NCT05393505 | The University of Hong Kong|Queen Mary Hospital, Hong Kong |
Neutropenic Fever
|
October 24, 2022 | Phase 4 |
| NCT03740659 | NTC srl |
Cataract
|
September 4, 2018 | Phase 2 |
| NCT04122287 | Shandong University |
Helicobacter Pylori Infection
|
November 1, 2019 | Phase 4 |
| NCT00645073 | Abbott |
Acute Bacterial Sinusitis
|
November 2003 | Phase 4 |
| NCT01131026 | Deva Holding A.S.|TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti.|TC Erciyes University |
Helicobacter Pylori Infection
|
June 2010 | Phase 3 |
| NCT00703313 | Santen Inc. |
Healthy
|
May 2008 | Phase 4 |
| NCT02981615 | Sheba Medical Center |
Prevention
|
August 1, 2017 | Phase 3 |
| NCT00431678 | Bayer |
Pneumonia
|
January 2004 | Phase 3 |
| NCT03850379 | Henry Ford Health System |
Prophylaxis|Stem Cell Transplant Complications
|
March 14, 2018 | Phase 2 |
| NCT03594149 | Centre Henri Becquerel |
Myelodysplastic Syndromes|Acute Myeloid Leukemia
|
July 18, 2018 | Phase 3 |
| NCT03138785 | Farabi Eye Hospital |
Treatment
|
January 1, 2015 | Not Applicable |
| NCT03003273 | All India Institute of Medical Sciences, New Delhi |
Neutropenia, Febrile|Pediatric Cancer
|
January 2017 | Phase 3 |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)